Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Feb 11;25(1):11-18.
doi: 10.1080/19768354.2021.1880967.

Gait parameters as tools for analyzing phenotypic alterations of a mouse model of Charcot-Marie-Tooth disease

Affiliations

Gait parameters as tools for analyzing phenotypic alterations of a mouse model of Charcot-Marie-Tooth disease

Sun Hee Hwang et al. Anim Cells Syst (Seoul). .

Abstract

Charcot-Marie-Tooth disease (CMT), a genetically heterogeneous group of diseases in the peripheral nervous system, is characterized by progressive and symmetrical distal weakness resulting in gait abnormality. The necessity of the diagnostic and prognostic biomarkers has been raised for both basic research and clinical practice in CMT. Since biomarkers for animal study of CMT are limited, we evaluated the feasibility of gait parameters as tool for measuring disease phenotype of CMT mouse model. Using a Trembler-J (Tr-J) mouse, a CMT type 1 (CMT1) mouse model, we analyzed kinematic parameters such as angles of hip, knee and ankle (sagittal plane), and spatial parameters including step width and stride length (transverse plane). Regarding of kinematic parameters, Tr-J mice exhibited less plantarflexed ankle during the swing phase and more dorsiflexed ankle at the terminal stance compared to control mice. The range of motion in ankle angle of Tr-J mice was significantly greater than that of control mice. In spatial parameter, Tr-J mice exhibited wider step width compared to control mice. These results are similar to previously reported gait patterns of CMT1 patients. In comparison with other markers such as nerve conduction study and rotarod test, gait parameters dynamically reflected the disease progression of CMT1 mice. Therefore, these data imply that gait parameters can be used as useful tools to analyzed the disease phenotype and progression during preclinical study of peripheral neuropathy such as CMT.

Keywords: Biomarker; Charcot-Marie-Tooth disease; gait analysis; mouse model.

PubMed Disclaimer

Conflict of interest statement

No potential conflict of interest was reported by the author(s).

Figures

Figure 1.
Figure 1.
MotoRator system and description of parameters for mouse gait analysis. (A) MotoRator system has a narrow channel with two mirros on both side of the channel to monitor lateral side of the mouse. (B) Description of sagittal plane parameters including angles of each hip, knee, and ankle. (C) Description of transverse plane parameters step width and stride length.
Figure 2.
Figure 2.
Kinematic data of Tr-J (n = 5) and WT mice (n = 5) at 14 weeks of age. (A) Hip angle (B) Knee angle (C) Ankle angle. Solid line, Tr-J mice; dashed line, WT mice. Thin lines, ± 1 standard deviation of Tr-J (solid) and WT (dashed) mice.
Figure 3.
Figure 3.
Follow-up data of sagittal plane parameters. * represent statistical significance between Tr-J and WT mice in the same time point: *, p < 0.05; and **, p < 0.01. # represents statistical significance between time points within same mouse group: #, p < 0.05 and ###, p < 0.001
Figure 4.
Figure 4.
Follow-up of transverse plane parameters. (A) Stride length. (B) Step width. * represents the statistical significance between Tr-J and WT mice in the same time point were analyzed: *, p < 0.05 and ***, p <0.001. # represents statistical significance between time points within same mouse group: ##, p < 0.01 and ###, p < 0.001
Figure 5.
Figure 5.
Nerve electrophysiologic parameters and rotarod performance data of Tr-J (n = 5) and WT mice (n = 5). (A) Motor nerve conduction velocity (MNCV). (B) Compound muscle action potential (CMAP) (C) Rotarod performance. *, p < 0.001.

Similar articles

Cited by

References

    1. Attarian S, Vallat JM, Magy L, Funalot B, Gonnaud PM, Lacour A, Péréon Y, Dubourg O, Pouget J, Micallef J, et al. . 2014. An exploratory randomised double-blind and placebo-controlled phase 2 study of a combination of baclofen, naltrexone and sorbitol (PXT3003) in patients with Charcot-Marie-Tooth disease type 1A. Orphanet J Rare Dis. 9:199. - PMC - PubMed
    1. Chung KW, Suh BC, Shy ME, Cho SY, Yoo JH, Park SW, Moon H, Park KD, Choi KG, Kim S, et al. . 2008. Different clinical and magnetic resonance imaging features between Charcot-Marie-Tooth disease type 1A and 2A. Neuromuscul Disord. 18(8):610–618. - PubMed
    1. Don R, Serrao M, Vinci P, Ranavolo A, Cacchio A, Ioppolo F, Paoloni M, Procaccianti R, Frascarelli F, De Santis F, et al. . 2007. Foot drop and plantar flexion failure determine different gait strategies in Charcot-Marie-Tooth patients. Clin Biomech (Bristol, Avon). 22(8):905–916. - PubMed
    1. Ferrarin M, Bovi G, Rabuffetti M, Mazzoleni P, Montesano A, Pagliano E, Marchi A, Magro A, Marchesi C, Pareyson D, Moroni I.. 2012. Gait pattern classification in children with Charcot-Marie-Tooth disease type 1A. Gait Posture. 35:131–137. - PMC - PubMed
    1. Ferrarin M, Lencioni T, Rabuffetti M, Moroni I, Pagliano E, Pareyson D.. 2013. Changes of gait pattern in children with Charcot-Marie-Tooth disease type 1A: a 18 months follow-up study. J Neuroeng Rehab. 10(1):65. - PMC - PubMed

LinkOut - more resources